NewsHK
Fidelity MSCI Health Care Index ETF (FHLC) offers a 0.08% expense ratio and a 1.2% trailing 12-month dividend yield, while iShares Biotechnology ETF (IBB) charges a 0.44% fee and provides a 0.2% yield.
The comparison highlights a tradeoff between the broad, lower-cost exposure of FHLC and the concentrated, higher-volatility focus of IBB on the biotechnology sector.
FHLC seeks to track a broad index of healthcare companies, holding 365 positions with healthcare representing 99% of the fund.
Its largest holdings are Eli Lilly & Co at 13.15%, Johnson & Johnson at 8.67%, and AbbVie at 6.76%.
Keep reading